Interview: More healthcare providers to adopt AI: Acer Medical

Acer Medical's forecast for increased AI adoption in Taiwan's healthcare sector reflects a reported change in sentiment among providers. The company suggests that hospitals are moving past initial doubts about AI's capabilities and are now focused on implementation strategies and overcoming associated barriers. This shift indicates a maturing understanding of AI's potential value within the local medical community.

The company, which develops AI-powered software for disease screening, medical records, and patient care, currently serves 600-700 healthcare institutions in Taiwan and over 20 countries. Its strategy includes deepening its ophthalmology portfolio with new retinal imaging applications and expanding its osteoporosis screening software, VeriOsteo OP, for broader body part analysis and North American regulatory approvals. This indicates a targeted approach to product development, leveraging existing successes and regional demand.

Acer Medical also plans to integrate large language models (LLMs) with wearable device data, initially for post-stroke care, to flag issues for nurses and send reminders. Furthermore, the company is expanding into data processing and system integration, utilizing Acer Group's hardware resources, including Altos Computing and Acer e-Enabling Service Business, to offer on-premises computing capacity. This suggests a move towards a more comprehensive service offering, combining software, data management, and hardware solutions.

Financially, Acer Medical reported a 50.1 percent year-on-year revenue increase to NT$51.39 million (US$1.62 million) in the first eight months of this year. With support from government healthcare programs and expanding cooperation, the company expects its full-year revenue to surpass last year's NT$60.05 million. This growth trajectory suggests that current strategies and market positioning are yielding positive financial results, reinforcing its capacity for continued development and expansion.